Abstract
Background:
One of the core responsibilities of health system is to treat tobacco dependence. This treatment includes different methods such as simple medical consultation, medication, and telephone counseling. To assess physicians’ opinions towards quality and result of different quit smoking methods provided in tobacco cessation services centers in Iran.
Methods:
In this cross-sectional and descriptive study, random sampling of all quit centers at country level was used to obtain a representative sample size of 100 physicians. Physicians completed a self-administered questionnaire which contained 10 questions regarding the quality, cost, effect, side effects, and the results of quitting methods using a 5-point Likert-type scale. Percentages, frequencies, mean, T-test, and variance analyses were computed for all study variables.
Results:
Most experts preferred to use combination quit smoking methods and then Nicotine Replacement Therapy (NRT) with 26 and 23, respectively. The least used methods were quit line and some methods without medication with 3 cases. The method which gained the maximum scores were telephone consultation, acupuncture, Willpower, Champix, combined method, and Interactive Voice Response (IVR) with the mean of 23.3, 23, 22.5, 22, 21.7 and 21.3, respectively. The minimum scores were related to e-cigarette, some methods without medication, and non-NRT medication with the mean of 12.3, 15.8 and 16.2, respectively. There were no significant differences in the mean of scores based on different cities (P = 0.256). Analysis of variance in mean scores showed significant differences in the means scores of different methods (P < 0.000).
Conclusions:
According to physicians acupuncture, personal methods and Champix are the most effective methods and these methods could be much more feasible and cost effective than other methods.
Keywords: Attitude, cigarette, experts, physicians, quitting
INTRODUCTION
Without effective tobacco control measures, it is estimated that by the year 2030 the annual global death toll will reach 8 million.[1,2] With current smoking patterns, approximately 500 million people alive today will eventually be killed by tobacco use.[3] Currently, there are an estimated 1.3 billion smokers in the world.[4] Most smokers are ready to quit, three out of four smokers say they want to quit.[5] A wide range of treatment options include behavioral and pharmacological therapies that have been proven to be effective for quitting smoking. There is no single approach that rejects the other therapies.[6] The cost of these methods is different and would not have the same effect on different smokers. It should be mentioned that treatments need to be tailored and delivered appropriately for individuals according to their age, gender, interest, needs and also cultural and local conditions.[7]
Repeated consultation at each clinical visit would reinforce the necessity for quitting.[8,9] Furthermore, consultation of health care providers can increase the quit rates to a great extent.[10] This intervention is relatively cost-effective because it is a part of available services, which people rarely use. Such interventions are very effective because they are provided by health care providers who are respected by most people, and smoker have good interaction with them.[11,12] Pharmaceutical therapies need less human resources and are more effective than behavioral therapies but more costly. However, for certain population groups (e.g., pregnant women and people with heart disease) the cost is very affordable. Minimal intervention by health professionals is not only an important and cost-effective approach, but also such interventions can help to change the culture.[13] Besides medical advice and telephone consultation for quitting, an effective method can include medication. Medication includes nicotine replacement Therapy (NRT) like patches, gum, nasal spray, mouth spray, lozenge and inhalator, as well as nonnicotine medications such as bupropion and varenicline.[14] Public health approaches such as mass media, quit and win efforts, telephone helplines play important roles in changing community norms for developing quit smoking programs.[15] Work with smokers to change their smoking behavior is an important goal, but the effect is limited if the environmental factors, that promote and support smoking, are not identified. Therefore, population interventions should be considered as a complementary approach in pharmacological and behavioral interventions.[16]
The ideal goal is to maximize options and opportunities for quit smoking interventions, according to people inside and outside of the boundary.[17]
Recently, after 10 years of the first educational intervention for quitting smoking and one or two complementary programs in Iran's health system network, and in some attached centers (including group therapy and free 15 mg nicotine patch) not an appropriate condition is observed whether in terms of human resources, consultation of medication services and the same old interventions are implemented and there are little documentation in this regard.[13,14,15,18,19,20,21] Therefore, the situation of different treatments needs to be studied and assessed and the most appropriate one to be selected and developed at country health system. Therefore, physicians who are conducting tobacco control, as experienced experts have been addressed. Our aim was to study and assess physicians’ opinions towards quality and result of different quit smoking methods provided in tobacco cessation services centers in Iran in order to identify those that could be as one of the most appropriate for Iran health system.
METHODS
This study is a cross-sectional and descriptive study conducted at Iran smoking cessation services centers in 2012–2013. In each Iran's province, there is a University under the supervision of Ministry of Health and Medical Education. Therefore, primary health care services are provided by universities of medical sciences and national tobacco control programs provided by these universities, and there is a person to coordinate these activities in the affiliated centers all across the provinces. There were approximately 50–60 smoking quit centers, which are working under supervision of health centers in primary health care system, but many of these were not active in presenting tobacco cessation services. For maximum coverage, 13 active centers in seven cities such as Tehran, Isfahan, Shiraz, Mashhad, Tabriz, Hamedan, and Sari were selected (whether public or private). After necessary coordination with the concerned authorities in deputy for health and curative affairs of the universities at each province, a random sampling of about 100 physicians with some expertise in tobacco treatment were asked to complete a survey on tobacco treatment approaches that they use, considering that for those who used different approaches more than one completed questionnaire received. The contents of the primarily structured questionnaire were designed by the first author based on the review of similar articles and the authors’ preliminary research. Its psychometric properties were evaluated in terms of face and content validity through a panel discussion with seven tobacco control experts in Iran who had experience in tobacco cessation programs until a convergence of opinions was reached. The reliability coefficient (Cronbach alpha) for the questionnaire was assessed through test-retest on a group of 15 physicians (α = 0.88). The questionnaire also was piloted before distribution.
In tobacco control expert panels, 30 scores were included for assessment. The questionnaire contained 10 questions (3 scores each) regarding the quality, cost, effect, side-effects and its consequences. The results of quitting methods using a 5-point Liker-type scale from 1 to 3 to have maximum 30 for each. Prior to the distribution of the questionnaire, the purpose and nature of this study were explained to the concerned authorities in each center and also to the randomly selected physicians and informed consent was obtained.
All survey responses were entered into a data set and doubled keyed to ensure accurate data entry. Percentages, frequencies, mean, t-test, and variance analyses were computed for all study variables. Analyses were conducted using SPSS 16.00 statistical software (SPSS Inc., Chicago, IL, USA).
RESULTS
In this study, a total of 182 completed survey questionnaire based on different used quit smoking approaches were received from 100 random selected physician. Most completed questionnaire were from Tehran (82 cases), using all methods that are while in other cities some methods were not accessible or the physicians have not used them. For example in Sari city, only nine completed questionnaire received. The most used methods were combination method (NRT and counseling) with 26 cases and NRT with 26 cases, respectively. The least used methods were quit line and some methods without medications (n = 3) [Table 1]. The mean of all methods was 19.7 ± 4 (minimum 11-maximum 30). The score 30 was given to Champix, combination method and education methods. The maximum scores were related to telephone consultation, acupuncture, willpower, Champix, combination methods and interactive voice response with the mean of 23.3, 23, 22.5, 22, 21.7, 21.3 and the minimum score were given to e-cigarette and some methods without medication and non-NRT medications with the mean of 12.3, 15.8 and 16.2, respectively [Table 2]. There was no significant difference in the mean of scores based on different cities (P = 0.256) [Table 3]. In an analysis of variance in mean score according to different methods there was a significant difference (P < 0.000) [Table 4].
Table 1.
Frequency distribution of tobacco control experts’ opinion by smoking quit methods and cities in Iran in 2012-2013

Table 2.
Prevalence and score obtained for each quit smoking method based on physicians’ opinion and according to their priority

Table 3.
Analysis of variance of mean scores for physicians’ opinions on quit smoking methods in different cities of Iran, 2012

Table 4.
Analysis of variance of mean score provided through physicians’ opinion toward different methods of quit smoking in Iran, 2012-2013 P<0.000

DISCUSSION
In this study, the attitudes of the physician toward different quitting methods revealed that telephone counseling, acupuncture, willpower, Champix, combination therapy, and quitline were known as the most effective methods in the country. The results of this study are important because few studies have assessed quality and result of different quit smoking methods and it is important to know the physicians’ opinions in order to update our services at the country level for enhancing success. In general, physicians usually consider the low-cost treatment as feasible and effective factor in selecting methods.
For example, most methods are reachable in public centers and mainly free and even expensive Champix pills once have been presented free in a governmental research for a while.[22] Acupuncture is offered in private clinics and with ordinary cost. Less price of treatment method or free of charge methods have been mentioned as a factor for better and more use in some studies.[23,24,25] Currently, the old quit smoking interventions are applied in Iran health system. Tobacco cessation counseling program and medication are still far from the ideal situation due to insufficient resources and there is considerable room for improvement. The study indicated that seventeen treatment methods for quit smoking can be divided in three groups with following items:
Group with high priority: Telephone-consultation, acupuncture, personal treatment, Champix, combination therapy, quit line·
Group with medium priority: Several medications, hypnosis, behavior therapy, nicotine replacement therapy, Zyban, self-learning material
Group with low priority: Education, quit and win, nonnicotine medication, some methods without medication, e-cigarette.
If NRT and Zyban, which are located in medium priority, would be transferred to high priority and if we don’t consider acupuncture, almost standard and advised methods are the same as other reported studies.[26,27] According to authors’ idea to explain these cases, these probabilities may be considered that the use of NRT made in the country has no proper quality. Zyban is very expensive despite availability. About acupuncture, perhaps it is reported more than it a reality that all these probabilities may be considered as commence of a new and supplemental study.
It has been observed that there is no significant difference in mean scores in quitting methods among seven cities and our survey shows that there are no significant differences on presented methods and services in cities and also in their result. We assumed the score of these methods will be more in Tehran with respect to other cities, but the highest rate has been reported in Sari city.
This point shows that quit-smoking methods services are uniform in different areas of the country that is mentioned in studies by Orleans et al.[28] Cokkinides et al.[29] and Fiore et al.[30]
According to conducted variance analysis to compare methods, despite the fact that there were significant differences, no significant differences were observed in existed quit methods in five groups in Table 4. It showed that one appropriate method might be selected among the methods in each group based on present conditions including its cost and feasibility.
It should be mentioned here that according to World Health Organization (WHO) report (MPOWER in 2011), presenting support for quit-smoking is one of the main six WHO recommendations, according to WHO Framework Convention on Tobacco Control (FCTC), and governments have responsibility to implement these conditions in best type. Hence in order to implement article-14 of the FCTC that is concerned with quit-smoking services, a WHO working group was formed during past 3 years, and its instruction and guidelines were prepared. Iran is also a member of this working group and also through implementation of Tobacco Control Programs (by Ministry of Health and Medical Education, nongovernmental organizations and Tobacco Control Research Centers) encouraged smokers to quit, to the extent that Iran has been mentioned in 47th page as one of the 19 countries that has proper success and also in 103rd page Iran is mentioned as one of the four countries that has national quit line and free services for quit-smoking and NRT services. However, authors examined conditions of quit-smoking in different cities, and it should be acknowledged that, unfortunately, this ideal situation is not observed.
CONCLUSIONS
This study revealed that more credit is allocated by physician to quit-smoking methods such as telephone-consultation, acupuncture, personal treatment, and Champix, respectively. Treatment costs are important for presenters of quit smoking services for smokers. There is no single miraculous method for quit smoking and some other methods are recommendable in some conditions.
Footnotes
Source of Support: Nil
Conflict of Interest: None declared.
REFERENCES
- 1.Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442. doi: 10.1371/journal.pmed.0030442. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr, Doll R. Mortality from smoking worldwide. Br Med Bull. 1996;52:12–21. doi: 10.1093/oxfordjournals.bmb.a011519. [DOI] [PubMed] [Google Scholar]
- 3.Levine R, Kinder M. Washington, DC: Center for Global Development; 2004. Millions Saved: Proven Success in Global Health. [Google Scholar]
- 4.Peto R, Lopez AD. Future worldwide health effects of current smoking patterns. In: Koop CE, Pearson CE, Schwarz MR, editors. Critical Issues in Global Health. San Francisco: Wiley (Jossey-Bass); 2001. pp. 154–61. [Google Scholar]
- 5.Jones JM. Smoking habits stable; Most would like to quit. [Last updated on 2007 Dec 06; Last cited on 2006 Jul 08]. Available from: http://www.gallup.com/poll/23791/Smoking-Habits-Stable-Most-Would-Like-Quit.aspx .
- 6.Wagena EJ, Zeegers MP, van Schayck CP, Wouters EF. Benefits and risks of pharmacological smoking cessation therapies in chronic obstructive pulmonary disease. Drug Saf. 2003;26:381–403. doi: 10.2165/00002018-200326060-00002. [DOI] [PubMed] [Google Scholar]
- 7.Feenstra TL, Hamberg-van Reenen HH, Hoogenveen RT, Rutten-van Mölken MP. Cost-effectiveness of face-to-face smoking cessation interventions: A dynamic modeling study. Value Health. 2005;8:178–90. doi: 10.1111/j.1524-4733.2005.04008.x. [DOI] [PubMed] [Google Scholar]
- 8.Solberg LI, Maciosek MV, Edwards NM, Khanchandani HS, Goodman MJ. Repeated tobacco-use screening and intervention in clinical practice: Health impact and cost effectiveness. Am J Prev Med. 2006;31:62–71. doi: 10.1016/j.amepre.2006.03.013. [DOI] [PubMed] [Google Scholar]
- 9.West R, Sohal T. “Catastrophic” pathways to smoking cessation: Findings from national survey. BMJ. 2006;332:458–60. doi: 10.1136/bmj.38723.573866.AE. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Fiore MC. Treating Tobacco Use and Dependence: A Public Health Service Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services, Press Briefing. [Last updated on 2000 Jun 27; Last cited on 2007 Dec 16]. Available from: http://www.surgeongeneral.gov/tobacco/mf062700.htm .
- 11.Bao Y, Duan N, Fox SA. Is some provider advice on smoking cessation better than no advice?. An instrumental variable analysis of the 2001 National Health Interview Survey. Health Serv Res. 2006;41:2114–35. doi: 10.1111/j.1475-6773.2006.00592.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Owen L. Impact of a telephone helpline for smokers who called during a mass media campaign. Tob Control. 2000;9:148–54. doi: 10.1136/tc.9.2.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Comparison of four methods of smoking withdrawal in patients with smoking related diseases. Report by a subcommittee of the Research Committee of the British Thoracic Society. Br Med J (Clin Res Ed) 1983;286:595–7. doi: 10.1136/bmj.286.6365.595. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Pfizer for Professionals. Mechanism of action of CHANTIX™ (varenicline) [Last accessed on 2007 Jan 08]. Available from: https://www.pfizerpro.com/product_info/chantix_dual_action.jsp .
- 15.Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev 2005. 2005;2:CD001292. doi: 10.1002/14651858.CD001292.pub2. [DOI] [PubMed] [Google Scholar]
- 16.Parrott S, Godfrey C, Raw M, West R, McNeill A. Guidance for commissioners on the cost effectiveness of smoking cessation interventions.Health Educational Authority. Thorax. 1998;53(Suppl 5 (Pt 2)):S1–38. [PMC free article] [PubMed] [Google Scholar]
- 17.Godfrey C. The economic and social costs of lung cancer and the economics of smoking prevention. Monaldi Arch Chest Dis. 2001;56:458–61. [PubMed] [Google Scholar]
- 18.Masjedi MR, Azaripour A, Heydari G, Hosseini M. Effective factors on smoking cessation among the smokers in the first “Smoking Cessation Clinic” in Iran. Tanaffos J Respir Dis. 2002;1:61–7. [Google Scholar]
- 19.Heydari G, Milani HS, Hosseini M, Masjedi MR. The effect of training and behavioral therapy: Recommendations on Smoking cessation. Tanaffos J Respir Dis. 2003;2:39–44. [Google Scholar]
- 20.Heydari G, Marashian M, Ebn Ahmady A, Masjedi M, Lando HA. Which form of nicotine replacement therapy is more effective for quitting smoking?. A study in Tehran, Islamic Republic of Iran. East Mediterr Health J. 2012;18:1005–10. doi: 10.26719/2012.18.10.1005. [DOI] [PubMed] [Google Scholar]
- 21.Heydari G, Jianfar G, Alvanpour A, Hesami Z, Talischi F, Masjedi MR. Efficacy of telephone quit line for smokers: 12 months follow up results. Tanaffos J Respir Dis. 2011;10:42–8. [PMC free article] [PubMed] [Google Scholar]
- 22.Heydari G, Talischi F, Tafti SF, Masjedi MR. Quitting smoking with varenicline: Parallel, randomised efficacy trial in Iran. Int J Tuberc Lung Dis. 2012;16:268–72. doi: 10.5588/ijtld.11.0183. [DOI] [PubMed] [Google Scholar]
- 23.Fiore MC. Rockville: US Department of Health and Human Services; 1996. Smoking Cessation: Clinical Practice Guidelines No. 18. Public Health Service, Agency for Health Care Policy and Research. AHCPR Publication No. 96.0692. [Google Scholar]
- 24.Geneva: WHO; 2001. World Health Organization. European partnership to reduce tobacco dependence: WHO evidence based recommendations on the treatment of tobacco dependence. [Google Scholar]
- 25.Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: A randomized controlled trial. JAMA. 2006;296:47–55. doi: 10.1001/jama.296.1.47. [DOI] [PubMed] [Google Scholar]
- 26.Centers for Disease Control and Prevention (CDC). Quitting smoking among adults – United States, 2001-2010. MMWR Morb Mortal Wkly Rep. 2011;60:1513–9. [PubMed] [Google Scholar]
- 27.Lucan SC, Katz DL. Factors associated with smoking cessation counseling at clinical encounters: The Behavioral Risk Factor Surveillance System (BRFSS) 2000. Am J Health Promot. 2006;21:16–23. doi: 10.4278/0890-1171-21.1.16. [DOI] [PubMed] [Google Scholar]
- 28.Orleans CT, Mabry PL, Abrams DB. Increasing tobacco cessation in America: A consumer demand perspective. Am J Prev Med. 2010;38:S303–6. doi: 10.1016/j.amepre.2010.01.013. [DOI] [PubMed] [Google Scholar]
- 29.Cokkinides VE, Ward E, Jemal A, Thun MJ. Under-use of smoking-cessation treatments: Results from the National Health Interview Survey, 2000. Am J Prev Med. 2005;28:119–22. doi: 10.1016/j.amepre.2004.09.007. [DOI] [PubMed] [Google Scholar]
- 30.Fiore MC, Novotny TE, Pierce JP, Giovino GA, Hatziandreu EJ, Newcomb PA, et al. Methods used to quit smoking in the United States. Do cessation programs help? JAMA. 1990;263:2760–5. [PubMed] [Google Scholar]
